Article List

WPRIM Management System> DCMS> The Korean Journal of Hepatology> 2008> 14

Volume: 14

1. Risk factors for mortality after surgery in patients with cirrhosis.	Page:541—545
2. Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease.	Page:1—3
3. Focal nodular hyperplasia-like nodule.	Page:537—540
4. Mucin hypersecreting cholangiocarcinoma.	Page:532—536
5. A case of hepatic epithelioid hemangioendothelioma that caused extrahepatic metastases without intrahepatic recurrence after hepatic resection.	Page:525—531
6. Treatment with pegylated interferon and ribavirin in a patient with fibrosing cholestatic hepatitis due to recurrent hepatitis C after liver transplantation.	Page:519—524
7. A case report of treatment with pegylated interferon alpha for lamivudine-resistant chronic hepatitis B virus infection.	Page:513—518
8. The efficacy of adefovir dipivoxil monotherapy and the incidence of genotypic resistance to adefovir dipivoxil in patients with lamivudine-resistant chronic hepatitis B infection.	Page:503—512
9. Efficacy of initial treatment with peginterferon alpha-2a versus peginterferon alpha-2b in combination with ribavirin in naive chronic hepatitis C patients living in Daejeon and Chungcheong Province in Korea: A comparative study.	Page:493—502
10. Clinical characteristics of 159 cases of acute toxic hepatitis.	Page:483—492
11. Clinical outcomes and predictive factors of spontaneous survival in patients with fulminant hepatitis A.	Page:474—482
12. Changes in liver stiffness during the course of acute hepatitis A.	Page:465—473
13. Hepatitis B virus genetic diversity and mutant.	Page:446—464
14. Treatment of chronic hepatitis C: Efficacy of initial treatment of peginterferon alpha-2a versus peginterferon alpha-2b plus ribavirin in naive chronic hepatitis C patients.	Page:443—445
15. Adefovir plus lamivudine combination therapy in lamivudine-resistant chronic hepatitis B.	Page:235—239
16. Radiologic findings of dysplastic nodule.	Page:231—234
17. Focal nodular hyperplasia-like nodule in liver cirrhosis.	Page:226—230
18. An adult case of glycogen storage disease type IIIa.	Page:219—225
19. Hepatitis B virus reactivation during chlorambucil and prednisolone treatment in an HBsAg-negative and anti-HBs-positive patient with B-cell chronic lymphocytic leukemia.	Page:213—218
20. Four cases of toxic liver injury associated with Dictamnus dasycarpus.	Page:206—212
21. Hepatitis B core antigen expression pattern predicts response to lamivudine therapy in patients with chronic hepatitis B.	Page:197—205
22. Expression of vascular endothelial growth factor (VEGF) family members and prognosis after hepatic resection in HBV-related hepatocellular carcinoma.	Page:185—196
23. Clinical feature of Fitz-Hugh-Curtis syndrome: Analysis of 25 cases.	Page:178—184
24. Incidence and risk factors of acute renal failure after transcatheter arterial chemoembolization for hepatocellular carcinoma.	Page:168—177
25. Serum hyaluronic acid level: Correlation with quantitative measurement of hepatic fibrosis in a cirrhotic rat model.	Page:159—167
26. Measurement of hepatic venous pressure gradient in liver cirrhosis: Relationship with the status of cirrhosis, varices, and ascites in Korea.	Page:150—158
27. Physiologic and pathologic experimental models for studying cholangiocytes.	Page:139—149
28. The relation between hepatic venous pressure gradient and complications of liver cirrhosis.	Page:136—138
29. Normal range of serum ALT level in patients with chronic hepatitis.	Page:116—121
30. Angiomyolipoma.	Page:113—115
31. Hepatic adenomatosis in glycogen storage disease.	Page:108—112
32. A case of ticlopidine induced acute cholestatic hepatitis and pure red cell aplasia.	Page:102—107
33. A case of allopurinol-induced granulomatous hepatitis with ductopenia and cholestasis.	Page:97—101
34. Hepatic myelopathy as a presenting neurological complication in patients with cirrhosis and spontaneous splenorenal shunt.	Page:89—96
35. Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease; Relation of non-alcoholic fatty liver disease to carotid atherosclerosis.	Page:77—88
36. The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis.	Page:67—76
37. Factors affecting initial virologic response and emergence of resistant mutants after adefovir treatment in lamivudine-resistant chronic hepatitis B patients.	Page:58—66
38. Comparison of therapeutic results between combination therapy of peginterferon alpha-2a plus ribavirin and interferon alpha-2b plus ribavirin according to treatment duration in patients with chronic hepatitis C.	Page:46—57
39. Clinical outcome of pegylated interferon and ribavirin therapy for chronic hepatitis C.	Page:36—45
40. Distribution of hepatitis C virus genotypes in Jeju Island.	Page:28—35
41. Nonalcoholic steatohepatitis: Pathogenesis and treatment.	Page:12—27
42. Recent developments in systemic chemotherapy for hepatocellular carcinoma.	Page:4—11
43. Natural history of gastric varices and risk factors for bleeding.	Page:331—341
44. Effects of pegylated interferon and ribavirin in Korean patients with chronic hepatitis C virus infection.	Page:318—330
45. Clinical application of stem cells in liver diseases.	Page:309—317
46. Anti-tumor mechanisms and regulation of survivin by selective cyclooxygenase-2 inhibitor.	Page:305—308
47. Problems faced by Korean patients with chronic liver disease and the role of the Korean Association for the Study of the Liver: Emphases on social discrimination, insufficiency of reimbursement coverage, and deficiency of the welfare system.	Page:125—135
48. Entecavir 1 mg therapy for lamivudine-refractory chronic hepatitis B.	Page:411—416
49. Imaging findings of hepatic adenoma.	Page:405—410
50. Epithelioid hemangioendothelioma of the liver.	Page:399—404
51. Hepatocellular carcinoma with lymphoid stroma: report of two cases.	Page:394—398
52. Three cases of multiple infarcted regenerative nodules in liver cirrhosis after gastrointestinal hemorrhage.	Page:387—393
53. A case of severe hypophosphatemia related to adefovir dipivoxil treatment in a patient with liver cirrhosis related to hepatitis B virus.	Page:381—386
54. Risk factors for early recurrence after surgical resection for hepatocellular carcinoma.	Page:371—380
55. Clinical outcomes of systemic chemotherapy in hepatocellular carcinoma patients with multiple lung metastases.	Page:360—370
56. Down-regulation of survivin in growth inhibition of hepatoma cells induced by a selective cyclooxygenase-2 inhibitor.	Page:351—359
57. Usefulness of liver stiffness measurement for predicting the presence of esophageal varices in patients with liver cirrhosis.	Page:342—350